Evidence map›Paper›PMID 31752974›Full record

ArticleBiology direct2019

A novel framework for horizontal and vertical data integration in cancer studies with application to survival time prediction models.

Iliyan Mihaylov, Maciej Kańduła, Milko Krachunov, Dimitar Vassilev

Abstract read
In one paragraph

Article in Biology direct, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Iliyan MihaylovFaculty of Mathematics and Informatics, Sofia University, "St. Kliment Ohridski", 5 James Bourchier Blvd., Sofia, 1164, Bulgaria.
Maciej KańdułaDepartment of Biotechnology, Boku University, Vienna, 1180, Austria.
Milko KrachunovFaculty of Mathematics and Informatics, Sofia University, "St. Kliment Ohridski", 5 James Bourchier Blvd., Sofia, 1164, Bulgaria.
Dimitar VassilevFaculty of Mathematics and Informatics, Sofia University, "St. Kliment Ohridski", 5 James Bourchier Blvd., Sofia, 1164, Bulgaria. dimitar.vassilev@fmi.uni-sofia.bg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently high-throughput technologies have been massively used alongside clinical tests to study various types of cancer. Data generated in such large-scale studies are heterogeneous, of different types and formats. With lack of effective integration strategies novel models are necessary for efficient and operative data integration, where both clinical and molecular information can be effectively joined for storage, access and ease of use. Such models, combined with machine learning methods for accurate prediction of survival time in cancer studies, can yield novel insights into disease development and lead to precise personalized therapies.

resultsWe developed an approach for intelligent data integration of two cancer datasets (breast cancer and neuroblastoma) - provided in the CAMDA 2018 'Cancer Data Integration Challenge', and compared models for prediction of survival time. We developed a novel semantic network-based data integration framework that utilizes NoSQL databases, where we combined clinical and expression profile data, using both raw data records and external knowledge sources. Utilizing the integrated data we introduced Tumor Integrated Clinical Feature (TICF) - a new feature for accurate prediction of patient survival time. Finally, we applied and validated several machine learning models for survival time prediction.

conclusionWe developed a framework for semantic integration of clinical and omics data that can borrow information across multiple cancer studies. By linking data with external domain knowledge sources our approach facilitates enrichment of the studied data by discovery of internal relations. The proposed and validated machine learning models for survival time prediction yielded accurate results. REVIEWERS: This article was reviewed by Eran Elhaik, Wenzhong Xiao and Carlos Loucera.

Indexed as

DNA Copy Number VariationsGenome, HumanBreast NeoplasmsComputational BiologyFemaleGene Expression Regulation, NeoplasticHumansMaleModels, GeneticNeuroblastomaSurvival AnalysisBreast cancerMachine learningNeuroblastomaSemantic data integrationSurvival time prediction

Identifiers

PMID31752974
PMCPMC6868770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.